Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06444360 · ClinicalTrials.gov registry record · NA

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

A NA study of HIV, sponsored by Westat.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT06444360 is a NA study of HIV that is actively recruiting participants, run by Westat. The registered enrollment target is 360 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06444360, a NA study of HIV, is actively recruiting participants, sponsored by Westat.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

Conditions Studied

Interventions

  • BEHAVIORAL IMPACT
  • BEHAVIORAL eSOC

Study Locations (2)

California

  • University of California, Los Angeles - Los Angeles

Rhode Island

  • Brown University - Providence

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-11-04
Est. Completion 2028-07-31
Phase NA

Sponsor

Westat

13 total trials

What the Registry Record Tells You About NCT06444360

The ClinicalTrials.gov registry entry for NCT06444360 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower). The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which IMPACT is the first listed.

NCT06444360 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06444360 about?

NCT06444360 is a clinical study titled "Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults". The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

What is the current status of trial NCT06444360?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-11-04. Estimated completion is 2028-07-31.

What conditions does trial NCT06444360 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06444360?

The interventions under investigation include: IMPACT (BEHAVIORAL), eSOC (BEHAVIORAL).

Who is sponsoring clinical trial NCT06444360?

This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06444360 being conducted?

This trial has 2 study locations across California, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.